Optic Neuritis Associated or Not with TNF Antagonists in Patients with Inflammatory Bowel Disease.

BACKGROUND AND AIMS Acute optic neuritis [ON] is an inflammatory condition affecting the optic nerve. Clinicians should suspect optic neuritis in cases of painful and rapidly progressive loss of central visual field. This condition may be associated with a multitude of diseases, and mostly with multiple sclerosis [MS] where it may present as an initial symptom. The literature reports that optic neuritis and MS occur in patients with inflammatory bowel disease [IBD] before and after the era of anti-tumour necrosis factor-α [TNFα] drugs. At the present moment, there is little consensus for managing this complication, currently treated with corticosteroids and discontinuation of the causative agents. METHODS We collected cases through a retrospective multicentre European Crohn's and Colitis Organisation CONFER [COllaborative Network For Exceptionally Rare case reports] project. We also performed a comprehensive retrospective search of the available literature on this topic. RESULTS We report herein 12 new cases of ON, including 10 under anti-TNF therapy, collected through the CONFER project. We also compare characteristics of ON associated or not with anti-TNFα agents. CONCLUSIONS The exceptional and current observation of distant family history of MS in 17% of our patients who developed ON, despite the small number and the lack of a control arm, might be an important signal that should be taken into account in our therapeutic strategies in the future.

[1]  I. Serageldin,et al.  Essentials , 2018, Make It Clear.

[2]  E. Eggenberger Initiation of anti-TNF therapy and the risk of optic neuritis: from the Safety Assessment of Biologic ThERapy (SABER) Study. , 2013, American journal of ophthalmology.

[3]  Hidetoshi Takahashi,et al.  Optic neuritis in a psoriatic arthritis patient treated by infliximab , 2013, The Journal of dermatology.

[4]  J. Carvalho,et al.  Optic neuritis after infliximab therapy , 2013, Rheumatology International.

[5]  F. Bérard,et al.  Optic neuritis associated with tumor necrosis factor-alfa antagonists for the treatment of psoriasis. , 2012, Journal of the American Academy of Dermatology.

[6]  N. Saffra,et al.  A case report of adalimumab-associated optic neuritis , 2012, Journal of Ophthalmic Inflammation and Infection.

[7]  J. Gómez-Reino,et al.  Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. , 2011, Seminars in arthritis and rheumatism.

[8]  J. Aasly Bilateral Optic Neuritis Associated with the Use of Infliximab , 2011, Case Reports in Ophthalmological Medicine.

[9]  R. Saxena,et al.  Management of optic neuritis , 2011, Indian journal of ophthalmology.

[10]  D. Miléa,et al.  [Is it optic neuritis? Differential diagnosis]. , 2010, Revue neurologique.

[11]  D. Goldstein,et al.  Optic Neuritis Associated with Adalimumab in the Treatment of Uveitis , 2010, Ocular immunology and inflammation.

[12]  C. Zois,et al.  Neurologic manifestations in inflammatory bowel diseases: current knowledge and novel insights. , 2010, Journal of Crohn's & colitis.

[13]  J. Chan,et al.  Infliximab and anterior optic neuropathy: case report and review of the literature , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.

[14]  K. Katsanos,et al.  Reversible bilateral optic neuritis after Infliximab discontinuation in a patient with Crohn's disease. , 2009, Journal of Crohn's & colitis.

[15]  H. Elloumi,et al.  Retrobulbar optic neuritis associated with infliximab in a patient with Crohn's disease. , 2009, Journal of Crohn's & colitis.

[16]  R. Manara,et al.  Sudden visual loss in a child with juvenile idiopathic arthritis-related uveitis , 2009, British Journal of Ophthalmology.

[17]  K. Katsanos,et al.  Spectrum and frequency of ophthalmologic manifestations in patients with inflammatory bowel disease: A prospective single‐center study , 2009, Inflammatory bowel diseases.

[18]  P. Munkholm,et al.  Occurrence of demyelinating diseases after anti-TNFα treatment of inflammatory bowel disease: A Danish Crohn Colitis Database study. , 2008, Journal of Crohn's & colitis.

[19]  R. Benecke,et al.  Cerebral MRI lesions and anti-tumor necrosis factor-alpha therapy , 2008, Journal of Neurology.

[20]  T. Kohnen,et al.  Anterior Optic Neuropathy Associated with Adalimumab , 2008, Ophthalmologica.

[21]  J. Pikkel Possible link between infliximab and optic neuritis. , 2008, The Israel Medical Association journal : IMAJ.

[22]  L. Peyrin-Biroulet,et al.  [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. , 2008, Gastroenterologie clinique et biologique.

[23]  N. Mumoli,et al.  Infliximab-induced retrobulbar optic neuritis. , 2007, QJM : monthly journal of the Association of Physicians.

[24]  H. Erdem,et al.  Optic neuritis occurring with anti-tumour necrosis factor α therapy , 2007 .

[25]  Shunsuke Kobayashi,et al.  New-onset demyelination induced by infliximab therapy in two rheumatoid arthritis patients , 2006, Clinical Rheumatology.

[26]  R. Turbin,et al.  Adalimumab-associated optic neuritis , 2006, Journal of the Neurological Sciences.

[27]  L. Provinciali,et al.  CNS demyelination during anti–tumor necrosis factor alpha therapy , 2006, Journal of Neurology.

[28]  L. Balcer Clinical practice. Optic neuritis. , 2006, The New England journal of medicine.

[29]  I. Avni,et al.  Optic neuritis associated with etanercept therapy for juvenile arthritis. , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[30]  J. Borrás-Blasco,et al.  Optic Neuritis with Concurrent Etanercept and Isoniazid Therapy , 2005, The Annals of pharmacotherapy.

[31]  J. Lewis,et al.  Increased risk for demyelinating diseases in patients with inflammatory bowel disease. , 2005, Gastroenterology.

[32]  M. Lauritzen,et al.  A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis. , 2005, Neurology.

[33]  M. Trojano,et al.  Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. , 2005, Investigative ophthalmology & visual science.

[34]  K. Papadakis,et al.  Association of anti-tumor necrosis factor therapy with the development of multiple sclerosis. , 2005, Journal of clinical gastroenterology.

[35]  B. Bodaghi,et al.  Névrite optique rétrobulbaire associée au traitement par infliximab , 2005 .

[36]  D. Milea,et al.  [Optic neuritis associated with infliximab]. , 2005, Journal francais d'ophtalmologie.

[37]  R. Gold,et al.  Plasma exchange for severe optic neuritis , 2004, Neurology.

[38]  J. Corbett Experience of the optic neuritis treatment trial , 2004, Current Neurology and Neuroscience Reports.

[39]  L. Mejico Infliximab-associated retrobulbar optic neuritis. , 2004, Archives of ophthalmology.

[40]  H. Herzenberg,et al.  Retrobulbar optic neuritis associated with infliximab in a patient with Crohn disease. , 2004, Annals of internal medicine.

[41]  B. Weinshenker,et al.  Demyelination During Anti-Tumor Necrosis Factor &agr; Therapy With Infliximab for Crohn's Disease , 2004, Inflammatory bowel diseases.

[42]  F. Ghanchi,et al.  Inflammatory bowel disease and the eye. , 2003, Survey of ophthalmology.

[43]  Michael Wall,et al.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.

[44]  D. Miller,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Management of Acute Optic Neuritis , 2022 .

[45]  R. Sergott,et al.  Retrobulbar optic neuritis associated with infliximab. , 2002, Archives of ophthalmology.

[46]  H. Völker‐Dieben,et al.  Cheilitis granulomatosa and optic neuropathy as rare extraintestinal manifestations of Crohn's disease. , 2002, Journal of clinical gastroenterology.

[47]  J. Richert,et al.  Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. , 2001, Arthritis and rheumatism.

[48]  V. Martinelli,et al.  Optic neuritis: differential diagnosis , 2001, Neurological Sciences.

[49]  W. Robinson,et al.  Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? , 2001, Arthritis and rheumatism.

[50]  W. K. Peterson,et al.  A randomized trial of intravenous immunoglobulin in inflammatory demyelinating optic neuritis , 2001, Neurology.

[51]  L. Melton,et al.  Concurrence of inflammatory bowel disease and multiple sclerosis. , 2000, Mayo Clinic proceedings.

[52]  S. Cole,et al.  The National Eye Institute Visual Function Questionnaire: experience of the ONTT. Optic Neuritis Treatment Trial. , 2000, Investigative ophthalmology & visual science.

[53]  E. G. de la Concha,et al.  Primary association of a TNF gene polymorphism with susceptibility to multiple sclerosis , 1999, Neurology.

[54]  H. Link,et al.  Incidence of optic neuritis in Stockholm, Sweden 1990–1995: I. Age, sex, birth and ethnic-group related patterns , 1998, Journal of the Neurological Sciences.

[55]  M. Brodsky,et al.  Visual function 5 years after optic neuritis: Experience of the optic neuritis treatment trial , 1997 .

[56]  H. Mcdevitt,et al.  The role of TNFα and related cytokines in the development and function of the autoreactive T-cell repertoire , 1997 .

[57]  L. Kurland,et al.  Optic neuritis , 1995, Neurology.

[58]  R. Beck,et al.  The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial. , 1994, Ophthalmology.

[59]  R. Beck,et al.  Brain magnetic resonance imaging in acute optic neuritis. Experience of the Optic Neuritis Study Group. , 1993, Archives of neurology.

[60]  R. Beck,et al.  Recovery from severe visual loss in optic neuritis. , 1993, Archives of ophthalmology.

[61]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[62]  C. Lowder,et al.  Posterior segment manifestations of inflammatory bowel disease. , 1991, Ophthalmology.

[63]  G. Striph,et al.  Visual recovery in patients with optic neuritis and visual loss to no light perception. , 1991, American journal of ophthalmology.

[64]  J. Rizzo,et al.  Risk of developing multiple sclerosis after uncomplicated optic neuritis , 1988, Neurology.

[65]  R. Burde,et al.  Optic neuritis in inflammatory bowel disease. , 1984, Journal of clinical neuro-ophthalmology.

[66]  J. Hermon-Taylor,et al.  ASSOCIATION OF ULCERATIVE COLITIS WITH MULTIPLE SCLEROSIS , 1982, The Lancet.

[67]  J. Gómez-Reino,et al.  Demyelinating disease in patients treated with TNF antagonists in rheumatology: data from BIOBADASER, a pharmacovigilance database, and a systematic review. , 2011, Seminars in arthritis and rheumatism.

[68]  M. Khamashta,et al.  Autoimmune diseases induced by biological agents: a double-edged sword? , 2010, Autoimmunity reviews.

[69]  L. Peyrin-Biroulet,et al.  [Retrobulbar optic neuritis during infliximab treatment for ulcerative colitis]. , 2008, Gastroenterologie clinique et biologique.

[70]  H. Erdem,et al.  Optic neuritis occurring with anti-tumour necrosis factor alpha therapy. , 2007, Annals of the rheumatic diseases.

[71]  Urso FORTE. Urso HIGHLIGHTS OF PRESCRIBING INFORMATION , 2007 .

[72]  M. Brodsky,et al.  Visual function more than 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2004, American journal of ophthalmology.

[73]  K Suzuki,et al.  TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. , 2001, Nature neuroscience.

[74]  G. Wong,et al.  TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination , 1998, Nature Medicine.

[75]  H. Mcdevitt,et al.  The role of TNF alpha and related cytokines in the development and function of the autoreactive T-cell repertoire. , 1997, Research in immunology.